病患血液管理市场规模、份额、成长分析（按产品、组件、最终用户和地区）- 产业预测，2025 年至 2032 年

2023 年患者血液管理市场规模价值 137.9 亿美元，预计将从 2024 年的 146.6 亿美元增长到 2032 年的 239 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.30%。

患者血液管理 (PBM) 市场正在经历显着增长，这得益于慢性病患病率的上升和外科手术的激增，以及人们对 PBM 益处的认识不断提高。这种综合方法旨在加强对需要输血的患者的护理并改善结果，同时最大限度地减少对输血的依赖。主要的市场驱动力包括心血管疾病和癌症等通常需要手术治疗的疾病的发生率不断上升。医疗保健提供者正在转向 PBM 策略，以减轻输血的风险和併发症。手术结果的改善、併发症的减少和住院时间的缩短正在推动对 PBM 解决方案的需求。透过推广输血替代方案和优化患者血液容量，PBM 实践正越来越多地被纳入全球医疗保健通讯协定。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2023年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

病患血液管理市场规模：依产品及复合年增长率（2024-2031）

• 市场概览
• 装置
• 血液处理设备
  • 离心
  • 血球处理设备
• 输血设备
  • 血液采集机
  • 细胞恢復系统
• 血液培养筛检装置
  • 自动化血液培养系统
  • 支援的设备
• 诊断和测试设备
  • 聚合酵素链锁反应
  • 血液分析仪
  • 血型测定仪
  • 次世代定序（NGS）平台
  • 其他的
• 血液储存装置
  • 冰箱
  • 冷冻库
• 配件
• 注射器和针头
• 管瓶和试管
• 血袋
• 其他配件
• 试剂和套件
• 培养基
• 血型试剂
• 玻片染色
• 检测试剂套件
• 其他的
• 软体
• 血库和输血软体
• 其他的

病患血液管理市场规模（依组成部分及复合年增长率） (2024-2031)

• 市场概览
• 全血
• 血液成分

病患血液管理市场规模（按最终用户和复合年增长率） (2024-2031)

• 市场概览
• 医院
• 血库

病患血液管理市场规模：按地区和复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 按部门分類的公司份额分析
  • 收益年比比较（2021-2023年）

主要企业简介

• Haemonetics Corporation（USA）
• Macopharma（France）
• Terumo Corporation（Japan）
• B. Braun SE（Germany）
• Grifols, SA（Spain）
• Asahi Kasei Corporation（Japan）
• BioMerieux SA（France）
• LivaNova PLC（UK）
• Fresenius Kabi AG（Germany）
• Roche Holding AG（Switzerland）
• Abbott Laboratories（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Danaher Corporation（USA）
• Siemens Healthineers（Germany）
• Johnson & Johnson（USA）
• Medtronic plc.（Ireland）
• BD（Becton, Dickinson and Company）（USA）
• Cardinal Health（USA）
• Teleflex Incorporated（USA）
• Stryker Corporation（USA）

结论和建议

Patient Blood Management Market size was valued at USD 13.79 Billion in 2023 and is poised to grow from USD 14.66 Billion in 2024 to USD 23.9 Billion by 2032, growing at a CAGR of 6.30% during the forecast period (2025-2032).

The patient blood management market is witnessing substantial growth, propelled by rising chronic disease prevalence and a surge in surgical procedures, alongside heightened awareness of PBM benefits. This comprehensive approach enhances patient care for those requiring blood transfusions, aiming to improve outcomes while minimizing transfusion reliance. Key market drivers include the increasing incidence of conditions such as cardiovascular issues and cancers that typically necessitate surgery. Healthcare providers are gravitating towards PBM strategies to lessen transfusion risks and complications. The focus on enhancing surgical outcomes, reducing complications, and decreasing hospital stays fuels the demand for PBM solutions. By promoting alternatives to transfusions and optimizing patient blood volumes, PBM practices are becoming increasingly integrated into global healthcare protocols.

Top-down and bottom-up approaches were used to estimate and validate the size of the Patient Blood Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Patient Blood Management Market Segments Analysis

Global Patient Blood Management Market is segmented by product, component, end user and region. Based on product, the market is segmented into instruments, blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, blood storage devices, accessories, syringes & needles, vials & tubes, blood bags, other accessories, reagents and kits, culture media, blood typing reagents, slide staining, assay kits, others, software, blood bank and transfusion software and others. Based on component, the market is segmented into whole blood and blood components. Based on end user, the market is segmented into hospitals and blood banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Patient Blood Management Market

The transfusion medicine sector has seen remarkable advancements, characterized by the introduction of innovative techniques and technologies aimed at enhancing blood management. These developments have greatly elevated the safety and efficacy of blood transfusions, fostering a growing inclination towards implementing patient blood management practices. As healthcare providers increasingly recognize the benefits of these improvements, the demand for efficient blood management solutions continues to rise, ultimately leading to better patient outcomes. This ongoing evolution in blood transfusion methods is crucial in driving the overall growth of the patient blood management market.

Restraints in the Patient Blood Management Market

The adoption of patient blood management practices generally requires a shift away from traditional transfusion methods and established medical standards. This transition is met with challenges such as overcoming resistance to change, addressing the preferences of healthcare providers, and ensuring sufficient training and education for all involved parties. These factors can hinder the effective implementation and broader acceptance of patient blood management strategies, as stakeholders may be reluctant to abandon familiar procedures in favor of newer protocols aimed at improving patient outcomes. Overcoming these obstacles is essential for fostering a more efficient and effective patient care environment.

Market Trends of the Patient Blood Management Market

The global Patient Blood Management (PBM) market is witnessing a notable trend towards personalized and evidence-based strategies to enhance blood transfusion practices. This shift underscores the necessity of customizing transfusion protocols to align with individual patient profiles and clinical circumstances, moving away from a generic methodology. Healthcare institutions are increasingly aware of the associated risks of unnecessary blood transfusions-including transfusion reactions, infectious complications, and escalated healthcare expenses. Consequently, there is a growing investment in data analytics and technology solutions aimed at improving decision-making processes and ensuring optimal blood utilization, thereby transforming the PBM landscape into a more patient-centric approach.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Patient Blood Management Market Size by Product & CAGR (2024-2031)

• Market Overview
• Instruments
• Blood Processing Devices
  • Centrifuge
  • Blood Cell Processors
• Blood Transfusion Devices
  • Apheresis Machines
  • Cell Salvage Systems
• Blood Culture Screening Devices
  • Automated Blood Culture Systems
  • Supporting Equipment
• Diagnostic & Testing Instruments
  • Polymerase Chain Reaction
  • Hematology Analyzer
  • Blood Grouping Analyzers
  • Next-Generation Sequencing (Ngs) Platforms
  • Others
• Blood Storage Devices
  • Refrigerator
  • Freezers
• Accessories
• Syringes & Needles
• Vials & Tubes
• Blood Bags
• Other Accessories
• Reagents And Kits
• Culture Media
• Blood Typing Reagents
• Slide Staining
• Assay Kits
• Others
• Software
• Blood Bank And Transfusion Software
• Others

Global Patient Blood Management Market Size by Component & CAGR (2024-2031)

• Market Overview
• Whole Blood
• Blood Components

Global Patient Blood Management Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Blood Banks

Global Patient Blood Management Market Size & CAGR (2024-2031)

• North America (Product, Component, End User)
  • US
  • Canada
• Europe (Product, Component, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Component, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Component, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Component, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Haemonetics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc. (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations